Nora Muhlegger
St Anna Children's Hospital
Vienna, Austria
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Prognostic Value of Molecular Genetic Measurable Residual Disease (MRD) Monitoring in Pediatric Acute Myeloid Leukemia Expressing KMT2A::MLLT10.
Journal: European journal of haematology
Published: May 12, 2025
No evidence of leukaemia (NEL) as a response criteria in paediatric AML: a multicentre analysis.
Journal: EClinicalMedicine
Published: November 27, 2024
Erratum to: Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard risk acute myeloid leukemia.
Journal: Haematologica
Published: July 01, 2024
Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms.
Journal: Nature communications
Published: June 12, 2023
Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG.
Journal: Cancers
Published: April 17, 2021
Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group.
Journal: Cancers
Published: January 20, 2021
Phospho-Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia.
Journal: HemaSphere
Published: June 27, 2019
Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia.
Journal: Annals of hematology
Published: August 08, 2016
Molecular characterization and clinical impact of t(11;15)(q23;q14-15) MLL-CASC5 rearrangement.
Journal: Haematologica
Published: January 16, 2014
Last Updated: 09/26/2026